Simufilam

simufilam · Cassava Sciences, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Simufilam, covering 2023-08-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease [Phase 3]